Table 1.
Patients’ clinical and pathological characteristics and the corresponding p-values of log-rank tests of univariate Kaplan–Meier analyses of the correlation of these variables with the 5-year overall survival rate (OS). p-values indicating a correlation are printed in bold.
| Category | n (%) | 5y-OS (%) | p-Value | |
|---|---|---|---|---|
| All | 216 (100) | 38 | ||
| Gender | Male | 182 (84.3) | 37 | 0.95 |
| Female | 34 (15.7) | 43 | ||
| Age [years] | <70 | 160 (74.1) | 42 | 0.003 |
| >70 | 56 (25.9) | 26 | ||
| Histotype | Adenocarcinoma | 162 (75) | 35 | 0.141 |
| Squamous cell carcinoma | 54 (25) | 42 | ||
| pT category (n = 200) |
T1 | 55 (27.5) | 65 | <0.001 |
| T2 | 50 (25) | 19 | ||
| T3 | 93 (46.5) | 28 | ||
| T4 | 2 (1) | 0 | ||
| pN category | N0 | 105 (48.6) | 58 | <0.001 |
| N1 | 73 (33.8) | 23 | ||
| N2 | 29 (13.4) | 13 | ||
| N3 | 9 (4.2) | 0 | ||
| pM category | M0 | 201 (93.1) | 40 | 0.001 |
| M1 | 15 (6.9) | 7 | ||
| UICC stage (n = 200) | I | 48 (24) | 65 | <0.001 |
| II | 52 (26) | 37 | ||
| III | 77 (38.5) | 29 | ||
| IV | 23 (11.5) | 4 | ||
| Neoadjuvant therapy | Yes | 115 (53.2) | 39 | 0.323 |
| No | 101 (46.8) | 38 | ||
| Adjuvant therapy | Yes | 57 (26.4) | 41 | 0.107 |
| No | 138 (63.9) | 37 | ||
| Unknown | 21 (9.7) |
UICC: Union Internationale Contre le Cancer.